Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Hotte, Naomi S C ^a   Salim, Saad Y ^a   Tso, Robert H ^a   Albert, Eric J ^a   Bach, Phil ^a   Walker, John ^a   Dieleman, Levinus A ^a   Fedorak, Richard N ^a   Madsen, Karen L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 17; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 9; NOD2 PROTEIN, HUMAN; PRIMER DNA; TLR9 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; MAJOR CLINICAL STUDY; MALE; MICROFLORA; REGULATORY MECHANISM; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SALMONELLA DUBLIN; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE REACTION; ULCERATIVE COLITIS; UPREGULATION; BIOPSY; CLUSTER ANALYSIS; COHORT ANALYSIS; COLON; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; METAGENOME; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; SALMONELLA;

BACTERIA (MICROORGANISMS); LACTOBACILLUS PLANTARUM; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR DUBLIN;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CLUSTER ANALYSIS; COHORT STUDIES; COLON; DNA PRIMERS; DNA, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS PLANTARUM; MALE; METAGENOME; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; SALMONELLA; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 9;

EID: 84861395076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037932     Document Type: Article

References (24)

1. Xavier R, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189.
3. Nishikawa J, Kudo T, Sakata S, Benno Y, Sugiyama T, (2009) Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol 44: 180-186.
4. Kang S, Denman SE, Morrison M, Yu Z, Dore J, et al. (2010) Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis 16: 2034-2042.
5. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
6. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, et al. (2011) Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60: 631-637.
7. Hedin C, Whelan K, Lindsay JO, (2007) Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proceedings of the Nutrition Society 66: 307-315.
8. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, et al. (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nature Cell Biology 8: 1327-1336.
9. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, et al. (2004) DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126: 1358-1373.
10. Campeau J, Albert JHotteN, Madsen K, (2010) Bacterial DNA differentially induces IL-17 producing T cell responses through interactions with intestinal epithelial and dendritic cells. Gastroenterology.
11. Rachmilewitz D, Karmeli F, Hayashi T, Reinus C, Rudensky B, et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
12. Kingma SD, Li N, Sun F, Valladares RB, Neu J, et al. (2011) Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J Nutr 141: 1023-1028.
13. Strober W, Fuss I, Mannon P, (2007) The fundamental basis of inflammatory bowel disease. Journal of Clinical Investigation 117: 514-521.
14. Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, et al. (2004) Crohn's disease is associated with a toll-like receptor-9 polymorphism.[comment]. Gastroenterology 127: 365-366.
15. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C, (2004) Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clinical Immunology 112: 85-91.
16. Chen KH, Zeng L, Gu W, Zhou J, Du DY, et al. (2011) Polymorphisms in the toll-like receptor 9 gene associated with sepsis and multiple organ dysfunction after major blunt trauma. Br J Surg 98: 1252-1259.
17. Sam-Agudu NA, Greene JA, Opoka RO, Kazura JW, Boivin MJ, et al. (2010) TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg 82: 548-555.
18. Torok HP, Glas J, Endres I, Tonenchi L, Teshome MY, et al. (2009) Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.[see comment]. American Journal of Gastroenterology 104: 1723-1733.
19. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
20. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, et al. (2008) IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 57: 1682-1689.
21. Lepage P, Hasler R, Spehlmann ME, Rehman A, Zvirbliene A, et al. (2011) Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141: 227-236.
22. Chen GY, Nunez G, (2011) Inflammasomes in Intestinal Inflammation and Cancer. Gastroenterology.
23. Andersson U, Tracey KJ, (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29: 139-162.
24. Hong J, Leung E, Fraser AG, Merriman TR, VIshnu P, et al. (2007) TLR2, TLR4, and TL9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J of Gastroenterology and Hepatology 22: 1760-1766.